Evidence map›Paper›PMID 40162834›Full record

ArticleThe European journal of neuroscience2025

Brainstem Neuroadaptations in Rodent Models of Parkinson's Disease.

Racha Al Tannir, Arnaud Pautrat, Remi Soutrenon, Paul G Overton, Veronique Coizet

Abstract read
In one paragraph

Article in The European journal of neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Racha Al TannirUniversité Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.
Arnaud PautratUniversité Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.
Remi SoutrenonUniversité Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.
Paul G OvertonDepartment of Psychology, University of Sheffield, Sheffield, UK.
Veronique CoizetUniversité Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France.ORCID 0000-0001-5192-6610

Funding

École doctorale Chimie et sciences du vivant, Université Grenoble AlpesInstitut National de la Santé et de la Recherche MédicaleNetwork of Centres of Excellence in Neurodegeneration
6 · The paper itself

Abstract

A classical theory of a key pathophysiological change in Parkinson's disease (PD) is that GABAergic neurons in the substantia nigra pars reticulata (SNr), an output structure of the basal ganglia, become hyperactive following the dopaminergic loss. Increased GABA release from the SNr neurons is thus likely to induce neuroadaptations in structures receiving a direct projection from the SNr, including the parabrachial nucleus (PBN), superior colliculus (SC), and periaqueductal gray (PAG). We have shown that the PBN indeed exhibits cellular and molecular changes in PD rat models. We thus expected the SC and the PAG to likewise show neuroplasticity. The objective of the present work was to evaluate the cellular and molecular plasticity in both the SC (lateral and medial) and the PAG in PD rats with a partial or total dopaminergic lesion. We used Golgi-Cox to measure the spine density and spine morphology and Western blot to analyze GABA

Indexed as

Brain StemNeuronal PlasticityParkinson DiseaseAnimalsDendritic SpinesDisease Models, AnimalDopaminergic NeuronsMaleOxidopaminePeriaqueductal GrayRatsRats, Sprague-DawleyReceptors, GABA-AOxidopamineReceptors, GABA-Adendritic spinesGABAA receptorsParkinson's diseaseperiaqueductal graysuperior colliculus

Identifiers

PMID40162834
PMCPMC11956546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.